Articles Referencing CYTX

Medivation Loss Narrower Than Expected - Analyst Blog

5/13/2013, 9:40 am from Zacks.com in Investing, Business, Stocks

Medivation Inc. ( MDVN ) reported a first-quarter loss of 36 cents per share, narrower than the Zacks Consensus Estimate of a loss of 41 cents per share. However, the company recorded... Read >>

Osiris Loss In-Line with Expectations - Analyst Blog

5/8/2013, 6:24 pm from Zacks.com in Investing, Business, Stocks

Osiris Loss In-Line with Expectations Osiris Therapeutics Inc. ( OSIR ) reported a first-quarter 2013 loss of 8 cents per share, in-line with the Zacks Consensus Estimate but wider than... Read >>

Joe Feshbach's Highest Conviction Position: A Regenerative Medicine 'Game Changer'

1/12/2010, 3:49 am from SeekingAlpha in Investing, Technology, Stocks

Joe Feshbach submits: Joseph L. Feshbach has over 25 years of professional investment experience, using both long and short equity strategies. Additionally he has been Chairman and CEO of... Read >>